GeneDx Holdings Corp. Finance Lease, Interest Payment on Liability
GeneDx Holdings Corp. (WGS) reported Finance Lease, Interest Payment on Liability of $3.03 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FinanceLeaseInterestPaymentOnLiability · last filed 2025-02-20
- GeneDx Holdings Corp. finance lease, interest payment on liability for the quarter ending 2023-06-30 was $800.00K, a 50.66% increase year-over-year.
- GeneDx Holdings Corp. finance lease, interest payment on liability for the quarter ending 2023-03-31 was $146.00K, a 73.55% decline year-over-year.
- GeneDx Holdings Corp. finance lease, interest payment on liability for the quarter ending 2022-12-31 was $595.00K.
- GeneDx Holdings Corp. finance lease, interest payment on liability for the quarter ending 2022-09-30 was $547.00K.
- GeneDx Holdings Corp. finance lease, interest payment on liability for fiscal 2024 was $3.03M, a 61.63% increase from fiscal 2023.
- GeneDx Holdings Corp. finance lease, interest payment on liability for fiscal 2023 was $1.87M, a 15.78% decline from fiscal 2022.
- GeneDx Holdings Corp. finance lease, interest payment on liability for fiscal 2022 was $2.23M.
| Period end | Finance Lease, Interest Payment on Liability 3 month | Finance Lease, Interest Payment on Liability 6 month | Finance Lease, Interest Payment on Liability 9 month | Finance Lease, Interest Payment on Liability 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.03M 10-K · filed 2025-02-20 | |||
| 2023-12-31 | $1.87M 10-K · filed 2025-02-20 | |||
| 2023-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $946.00K 10-Q · filed 2023-08-08 | $1.54M derived: sum of 3 quarters · filed 2024-02-23 | $2.09M derived: sum of 4 quarters · filed 2024-02-23 |
| 2023-03-31 | $146.00K 10-Q · filed 2023-05-09 | $741.00K derived: sum of 2 quarters · filed 2024-02-23 | $1.29M derived: sum of 3 quarters · filed 2024-02-23 | $1.82M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-12-31 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $1.14M derived: sum of 2 quarters · filed 2024-02-23 | $1.67M derived: sum of 3 quarters · filed 2024-02-23 | $2.23M 10-K · filed 2024-02-23 |
| 2022-09-30 | $547.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.08M derived: sum of 2 quarters · filed 2022-11-14 | $1.63M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $531.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.08M 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | $552.00K 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |